Article

Chemogenomics Mapping of Potential Drugs and Targets for Treatment of Multiple Myeloma

2021-02-09

Abstract excerpt

<title>Abstract</title> <p>Multiple myeloma (MM) is the second common hematological malignancy affecting about 352,000 worldwide. Some subgroups of MM patients still cannot benefit from the currently available anti-MM drugs and therefore are at high risk of death. The pathological mechanism of MM remains to be unraveled. The identification of a global gene signature for MM might lead toward development of novel d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7c103650-56ca-5240-b431-896c9b31b556
DOI: 10.21203/rs.3.rs-164458/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Chemogenomics Mapping of Potential Drugs and Targets for Treatment of Multiple MyelomaDOI 10.21203/rs.3.rs-164458/v1Read

Genome-Wide Identification of Potential Biomarkers in Multiple Myeloma Using Meta-Analysis of mRNA and miRNA Expression DataSemantic proximity Read

Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment.Semantic proximity Read

A novel ferroptosis-related gene signature for predicting prognosis in multiple myelomaSemantic proximity Read

Identification of candidate therapeutics and signaling pathways for multiple myelomaSemantic proximity Read

Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple MyelomaSemantic proximity Read

A gene expression signature based on cell-death related gene expression in multiple myelomaSemantic proximity Read

Mitophagy-related gene signature for predicting the prognosis of multiple myelomaSemantic proximity Read

Identification of Pathogenesis and Prognoses of Relapse in Myeloma by Bioinformatic MethodSemantic proximity Read

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myelomaSemantic proximity Read

Identification of a novel cuproptosis‐related gene signature for multiple myeloma diagnosisSemantic proximity Read

Comparison of Transcriptomic Changes in Younger and Older Multiple Myeloma Patients from the MMRF-CoMMpass Study RNA-Seq DataSemantic proximity Read

Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verificationSemantic proximity Read